● Recruiting

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Condition: Atherosclerotic Cardiovascular Disease (ASCVD) · Sponsor: Novartis Pharmaceuticals

PhasePhase 3

Planned participants340

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with ASCVD who have elevated lipoprotein(a) (Lp(a)), and who are on background inclisiran treatment for elevated low-density lipoprotein cholesterol (LDL-C).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (95)

Parkway Medical Center	Birmingham, Alabama, United States	Recruiting
Clinical Research Inst of Arizona	Sun City West, Arizona, United States	Recruiting
National Heart Institute	Beverly Hills, California, United States	Recruiting
Interv Cardiology Med Grp	West Hills, California, United States	Recruiting
Excel Medical Clinical Trials LLC	Boca Raton, Florida, United States	Active Not Recruiting
Jacksonville Center for Clinical	Jacksonville, Florida, United States	Recruiting
K2 Medical Research LLC	Maitland, Florida, United States	Active Not Recruiting
University of Miami Hospital	Miami, Florida, United States	Recruiting
Baptist Health South	Miami, Florida, United States	Recruiting
Inpatient Research Clinical LLC	Miami Lakes, Florida, United States	Active Not Recruiting
FXM Clin Res Miramar LLC	Miramar, Florida, United States	Recruiting
Ocala Cardiovascular Research	Ocala, Florida, United States	Recruiting

+ 83 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06813911